AZXOA still trading at a discount...My thoughts are we will see a bit of movement in feb/mar as we move towards the updated JORC.. Could be an interesting couple of months ahead..
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%